WallStreetZenWallStreetZen

NASDAQ: KRBP
Kiromic Biopharma Inc Stock

$0.27+0.04 (+17.39%)
Updated Feb 6, 2023
KRBP Price
$0.27
Fair Value Price
$0.26
Market Cap
$4.84M
52 Week Low
$0.15
52 Week High
$1.04
P/E
-0.1x
P/B
17.02x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$38.30M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
44.83
Operating Cash Flow
-$29M
Beta
0.88
Next Earnings
Mar 9, 2023
Ex-Dividend
N/A
Next Dividend
N/A

KRBP Overview

Kiromic BioPharma Incorporated is developing multi-indication allogeneic T cell therapies that exploit the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma was founded in 2006 and is headquartered in Houston, TX.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KRBP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

KRBP ($0.27) is overvalued by 3.59% relative to our estimate of its Fair Value price of $0.26 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
KRBP ($0.27) is not significantly undervalued (3.59%) relative to our estimate of its Fair Value price of $0.26 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
KRBP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more KRBP due diligence checks available for Premium users.

Be the first to know about important KRBP news, forecast changes, insider trades & much more!

KRBP News

Valuation

KRBP fair value

Fair Value of KRBP stock based on Discounted Cash Flow (DCF)
Price
$0.27
Fair Value
$0.26
Overvalued by
5.54%
KRBP ($0.27) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
KRBP ($0.27) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
KRBP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

KRBP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.1x
Industry
11.5x
Market
14.99x

KRBP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
17.02x
Industry
5.06x
KRBP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

KRBP's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.9M
Profit Margin
0%
KRBP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$13.0M
Liabilities
$12.7M
Debt to equity
44.83
KRBP's short-term liabilities ($11.11M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KRBP's short-term assets ($2.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KRBP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.1M
Investing
$132.4k
Financing
-$114.9k
KRBP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

KRBP vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
KRBP$4.84M+15.72%-0.10x17.02x
VYNT$4.91M0.00%-0.10x0.35x
HSTO$4.96M+2.65%-0.28x0.29x
ONCS$4.99M-1.18%-0.09x-5.07x
NBY$4.55M-0.81%-0.44x0.33x

Kiromic Biopharma Stock FAQ

What is Kiromic Biopharma's quote symbol?

NASDAQ: KRBP) Kiromic Biopharma trades on the NASDAQ under the ticker symbol KRBP. Kiromic Biopharma stock quotes can also be displayed as NASDAQ: KRBP.

If you're new to stock investing, here's how to buy Kiromic Biopharma stock.

What is the 52 week high and low for Kiromic Biopharma (NASDAQ: KRBP)?

(NASDAQ: KRBP) Kiromic Biopharma's 52-week high was $1.04, and its 52-week low was $0.15. It is currently -74.52% from its 52-week high and 76.67% from its 52-week low.

How much is Kiromic Biopharma stock worth today?

(NASDAQ: KRBP) Kiromic Biopharma currently has 18,246,718 outstanding shares. With Kiromic Biopharma stock trading at $0.27 per share, the total value of Kiromic Biopharma stock (market capitalization) is $4.84M.

Kiromic Biopharma stock was originally listed at a price of $11.50 in Oct 16, 2020. If you had invested in Kiromic Biopharma stock at $11.50, your return over the last 2 years would have been -97.7%, for an annualized return of -84.82% (not including any dividends or dividend reinvestments).

How much is Kiromic Biopharma's stock price per share?

(NASDAQ: KRBP) Kiromic Biopharma stock price per share is $0.27 today (as of Feb 6, 2023).

What is Kiromic Biopharma's Market Cap?

(NASDAQ: KRBP) Kiromic Biopharma's market cap is $4.84M, as of Feb 8, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Kiromic Biopharma's market cap is calculated by multiplying KRBP's current stock price of $0.27 by KRBP's total outstanding shares of 18,246,718.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.